Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corzo, D
Right arrow Articles by Yunis, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corzo, D
Right arrow Articles by Yunis, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

The major histocompatibility complex region marked by HSP70-1 and HSP70- 2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups

D Corzo, JJ Yunis, M Salazar, JA Lieberman, A Howard, Z Awdeh, CA Alper and EJ Yunis

Division of Immunogenetics, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

Genes of the major histocompatibility complex (MHC) have been associated with susceptibility to drug-induced adverse reactions. We previously found that clozapine-induced agranulocytosis (CA) is associated with the HLA-DRB1*0402, DRB4*0101, DQB1*0302, DQA1*0301 haplotype in Ashkenazi Jewish patients and with the HLA-DRB1*1601, DRB5*02, DQB1*0502, DQA1*0102 haplotype in non-Jewish patients. In the present study, we tested the hypothesis that the variants of the heat- shock protein 70 (HSP-70) encoded by the HSP-70 loci located within the MHC region and known to be involved in apoptosis and regulation of cell proliferation could play an important role in molecular mechanisms of CA. First, we analyzed HSP70-2 polymorphism in risk-associated haplotypes from HLA homozygous cells and normal individuals and confirmed that the HSP70-2 9-kb variant was associated invariably with DR4 (HLA-DRB1*0402, DQB1*0302) and DR2 (HLA-DRB1*01601, DQB1*0502, DQA1*0102 and HLA-DRB1*1501, DQB1*0602) haplotypes, which were the haplotypes found increased in Jewish and non-Jewish patients with CA, respectively. The 9.0-kb variant was also found to be associated with HLA-B44, DRB1*0401 and HLA-B44, DRB1*07 haplotypes. Second, in patients with CA (12 Ashkenazi Jewish and 20 non-Jewish patients), HSP70-1 A and HSP70-2 9.0-kb variants were associated with the MHC haplotypes found by us to be markers of susceptibility to CA. The clozapine-treated control group had an excess number of HSP70-1 C and HSP70-2 8.5-kb variants, consistent with genetic resistance to CA associated with those variants. This finding supports our hypothesis that a dominant gene within the MHC region (marked by HSP70-1 and HSP70-2), but not necessarily HLA, is associated with CA in two different ethnic groups.

Volume 86, Issue 10, pp. 3835-3840, 11/15/1995
Copyright © 1995 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
K. J. Aitchison, M. W. Jann, J. H. Zhao, T. Sakai, H. Zaher, K. Wolff, D. A. Collier, R. W. Kerwin, and F. J. Gonzalez
Clozapine pharmacokinetics and pharmacodynamics studied with CYP1A2-null mice
J Psychopharmacol, July 1, 2000; 14(4): 353 - 359.
[Abstract] [PDF]


Home page
Mol. Pharmacol.Home page
D. P. Williams, M. Pirmohamed, D. J. Naisbitt, J. P. Uetrecht, and B. K. Park
Induction of Metabolism-Dependent and -Independent Neutrophil Apoptosis by Clozapine
Mol. Pharmacol., July 1, 2000; 58(1): 207 - 216.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
C. Gaudin, F. Kremer, E. Angevin, V. Scott, and F. Triebel
A hsp70-2 Mutation Recognized by CTL on a Human Renal Cell Carcinoma
J. Immunol., February 1, 1999; 162(3): 1730 - 1738.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
I. Gardner, J. S. Leeder, T. Chin, N. Zahid, and J. P. Uetrecht
A Comparison of the Covalent Binding of Clozapine and Olanzapine to Human Neutrophils In Vitro and In Vivo
Mol. Pharmacol., June 1, 1998; 53(6): 999 - 1008.
[Abstract] [Full Text]


Home page
BloodHome page
D. Turbay, J. Lieberman, C. A. Alper, J. C. Delgado, D. Corzo, J. J. Yunis, and E. J. Yunis
Tumor Necrosis Factor Constellation Polymorphism and Clozapine-Induced Agranulocytosis in Two Different Ethnic Groups
Blood, June 1, 1997; 89(11): 4167 - 4174.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
N. S. Young and J. Maciejewski
The Pathophysiology of Acquired Aplastic Anemia
N. Engl. J. Med., May 8, 1997; 336(19): 1365 - 1372.
[Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1995 by American Society of Hematology         Online ISSN: 1528-0020